Understanding Your Child's MPI-CDG Diagnosis

Receiving a diagnosis of MPI-CDG (also known as CDG-Ib) can feel like entering an entirely new world. You may have spent months or even years searching for answers to your child’s digestive issues or blood sugar fluctuations. While finding out your child has an exceptionally rare genetic condition is overwhelming, MPI-CDG is unique among the family of Congenital Disorders of Glycosylation (CDGs). It is often called a “treatable CDG” because it has a specific, effective therapy that can significantly improve a child’s health and future ^[1][2].

An Exceptionally Rare Condition

MPI-CDG is one of the rarest conditions in the world. As of 2023, a review of published literature counted approximately 52 documented cases across 17 different countries, though this reflects reported cases rather than the true global prevalence ^[3]. It occurs because of a deficiency in an enzyme (a protein that helps with chemical reactions) called mannose phosphate isomerase ^[4].

Without enough of this enzyme, the body cannot properly process certain sugars to build “sugar chains” that decorate other proteins. These sugar chains are essential for proteins to work correctly throughout the body ^[4][5]. Because the condition is so rare, many doctors may never have seen a case before. Finding a specialized metabolic team is an important first step in managing your child’s care.

A Focus on the Body, Not the Brain

One of the most important things for parents to know about MPI-CDG is what it typically does not affect. In most other types of CDG, children face significant challenges with brain development, muscle tone, and intellectual abilities ^[6][7].

In contrast, children with MPI-CDG usually have typically preserved cognitive and neurological development ^[1][3]. While the condition can be physically taxing, it does not typically cause intellectual disability, though severe or prolonged episodes of low blood sugar can carry a risk of brain injury. Your child’s personality, learning potential, and “who they are” generally remain untouched by the primary disorder, and routine developmental surveillance is recommended.

How MPI-CDG Affects the Body

Most children with MPI-CDG show symptoms before the age of two ^[3]. The condition primarily involves four main systems:

• Gastrointestinal (GI) System: This is often the first sign parents notice. Children may have chronic diarrhea, vomiting, or a condition called protein-losing enteropathy, where the body loses a vital protein called albumin through the gut ^[3][1].
• Liver: The liver may become enlarged (hepatomegaly) or develop scarring (fibrosis) ^[3]. Liver enzymes are often elevated in blood tests, though the liver usually continues to function well enough for daily life ^[1].
• Blood Sugar: Many children experience hyperinsulinemic hypoglycemia—episodes of dangerously low blood sugar caused by the body releasing too much insulin ^[3][8].
• Coagulation (Blood Clotting and Bleeding): The body may not produce enough of the proteins that help blood clot correctly. This can lead to a higher risk of blood clots (thrombosis), even though the child may also have “thin” blood on certain lab tests that increases bleeding risks ^[9][3].

A Highly Treatable Condition

The most encouraging news for families is the availability of D-mannose. This is a simple sugar that can be taken as an oral supplement. Because the body’s “blockage” in MPI-CDG happens before mannose is used, giving this sugar directly “bypasses” the problem and allows the body to build those essential sugar chains ^[4][5].

When treatment with D-mannose begins, many symptoms can improve, though response times vary from child to child:

• Diarrhea and low blood sugar episodes often resolve within 1 to 2 weeks ^[2][8].
• Protein levels in the blood typically return to normal, reducing swelling and digestive issues ^[2].
• While liver scarring may persist, the overall health of the liver often stabilizes ^[10][11].

Treatment is generally lifelong, as stopping the supplement can cause symptoms to return quickly ^[10][12]. While D-mannose is highly effective, your medical team will still monitor your child’s liver and blood clotting factors closely to ensure they stay healthy as they grow ^[2][10]. Organizing your child’s care with a multidisciplinary team—including specialists in metabolism, GI, and the liver—is the best way to support their long-term health ^[1].